CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 1987; 37:302-320
doi: 10.3322/canjclin.37.5.302
© 1987 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glover, D. J.
Right arrow Articles by Glick, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glover, D. J.
Right arrow Articles by Glick, J. H.

CA: A Cancer Journal for Clinicians, Vol 37, 302-320, Copyright © 1987 by American Cancer Society

Metabolic Oncologic Emergencies

Donna J. Glover MD1 and John H. Glick MD2

1 Assistant Professor of Medicine in the Hematology-Oncology Section of the University of Pennsylvania Cancer Center in Philadelphia, Pennsylvania.
2 Professor of Medicine and Director of the University of Pennsylvania Cancer Center in Philadelphia, Pennsylvania.

With improvements in antitumor therapy, it is important to recognize life-threatening metabolic emergencies that may be reversed by prompt treatment. Accurate diagnosis and treatment of metabolic emergencies may both improve quality of life and increase survival, allowing more oncology patients to receive an adequate trial of definitive therapy designed to eradicate or palliate their disease.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by American Cancer Society.